Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
【発明の名称】腺維芽細胞成長受容体-3又は-2を発現する細胞を標的化するための方法
Document Type and Number:
Japanese Patent JP2003515567
Kind Code:
A
Abstract:
Fibroblast growth factor-18 (FGF-18) binds with FGF receptors-2 and -3. Compositions comprising an FGF-18 component can be used to target cells that express these receptors. Suitable targets include tumor cells that express constitutively activated forms of FGF receptors-2 and -3.

Inventors:
West, James W.
Application Number:
JP2001541520A
Publication Date:
May 07, 2003
Filing Date:
November 28, 2000
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Zymogenetics, Incorporated
International Classes:
A61K45/00; A61K38/00; A61K38/18; A61K47/48; A61P35/00; C07K14/50; (IPC1-7): A61K38/00; A61K45/00; A61P35/00; C07K14/50
Foreign References:
US5911995A1999-06-15
US5911995A1999-06-15
Other References:
JPN6010060750; Lappi DA.: 'Tumor targeting through fibroblast growth factor receptors.' Semin Cancer Biol. 6巻5号, 199510, pp.279-288
JPN6010060752; Ohbayashi N et al.: 'Structure and expression of the mRNA encoding a novel fibroblast growth factor, FGF-18.' J Biol Chem. 273巻29号, 19980717, pp.18161-18164
JPN6010060753; Pastan I et al.: 'Immunotoxins' Cell 47巻5号, 19861205, pp.641-648
JPN6010060755; Goldenberg DM.: 'New developments in monoclonal antibodies for cancer detection and therapy.' CA Cancer J Clin. 44巻1号, 199402, pp.43-64
JPN6010060756; Murahashi N et al.: 'Hepatic accumulation of glutamic acid branched neogalactosyllipid modified liposomes.' Biol Pharm Bull. 20巻3号, 199703, pp.259-266
JPN6011063895; MacArthur CA et al.: 'FGF-8 isoforms activate receptor splice forms that are expressed in mesenchymal regions of mouse dev' Development Vol.121 no.11, 199511, pp.3603-3613
JPN6011063896; Marsh SK et al.: 'Increased expression of fibroblast growth factor 8 in human breast cancer.' Oncogene. Vol.18 no.4, 199901, pp.1053-1060
JPN6011063897; Chesi M et al.: 'The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in I' Blood. Vol.92 no.9, 19981101, pp.3025-3034
JPN6010060750; Lappi DA.: 'Tumor targeting through fibroblast growth factor receptors.' Semin Cancer Biol. 6巻5号, 199510, pp.279-288
JPN6010060752; Ohbayashi N et al.: 'Structure and expression of the mRNA encoding a novel fibroblast growth factor, FGF-18.' J Biol Chem. 273巻29号, 19980717, pp.18161-18164
JPN6010060753; Pastan I et al.: 'Immunotoxins' Cell 47巻5号, 19861205, pp.641-648
JPN6010060755; Goldenberg DM.: 'New developments in monoclonal antibodies for cancer detection and therapy.' CA Cancer J Clin. 44巻1号, 199402, pp.43-64
JPN6010060756; Murahashi N et al.: 'Hepatic accumulation of glutamic acid branched neogalactosyllipid modified liposomes.' Biol Pharm Bull. 20巻3号, 199703, pp.259-266
JPN6011063895; MacArthur CA et al.: 'FGF-8 isoforms activate receptor splice forms that are expressed in mesenchymal regions of mouse dev' Development Vol.121 no.11, 199511, pp.3603-3613
JPN6011063896; Marsh SK et al.: 'Increased expression of fibroblast growth factor 8 in human breast cancer.' Oncogene. Vol.18 no.4, 199901, pp.1053-1060
JPN6011063897; Chesi M et al.: 'The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in I' Blood. Vol.92 no.9, 19981101, pp.3025-3034
Attorney, Agent or Firm:
Takashi Ishida (4 others)